Nasdaq Panel Denies OSR Health Continued Listing Request
Nasdaq's Hearings Panel denied OSR Health's request for continued listing on October 23, 2026, and determined to delist its securities after the company failed to meet the minimum bid price requirement. Trading had been suspended since August 26, 2026.
On October 23, 2026, Nasdaq's Hearings Panel denied OSR Health's request for continued listing and determined to delist its securities after the company failed to meet the minimum bid price requirement in Nasdaq Listing Rule 5550(a)(2). Trading had been suspended since August 26, 2026, and the secu…